Advertisement
Screener

Opaleye Management Inc. Historic Quarter Change: Foreign Other Stocks, Reduced

Opaleye Management Inc. historic quarter change: Foreign Other Stocks, Reduced

In shares no fund filing gives a ticker for, so this site has no page for them (depositary receipts and foreign shares traded over the counter), over 21 quarters from 2013-12-31 to 2026-06-30, Opaleye Management Inc. opened 7 positions, added to 3, reduced 2 and sold out of 8.

  • Q4 2014: Stock BIOLINERX LTD; Country of operation —; Class COM; Shares before 490,000.
  • Q3 2014: Stock BIOLINERX LTD; Country of operation —; Class COM; Shares before 650,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1595855), 21 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-04-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-15); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-29); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-27); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-13); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2014BIOLINERX LTD
CUSIP 09071M106
COM490,000250,000-240,000$754,600,000$405,000-$754,195,0002015-02-13
Q3 2014BIOLINERX LTD
CUSIP 09071M106
COM650,000490,000-160,000$1,352,000$754,600,000+$753,248,0002014-11-14

Similar Firms

Firm NameCountry13F ValueHoldings
Sargent Investment Group, LLCUnited States$0.759B271
Walkner Condon Financial Advisors LLCUnited States$0.759B322
Cannon Financial Strategists, Inc.United States$0.761B109
CULLEN INVESTMENT GROUP, LTD.United States$0.758B179
Integrity Advisory Solutions, LLCUnited States$0.757B293
Tennessee Valley Asset Management PartnersUnited States$0.757B191
Ranmore Fund Management LtdUnited Kingdom$0.757B20
Boxer Capital Management, LLCUnited States$0.762B54
Gibbs Wealth ManagementUnited States$0.762B433
Meridian Wealth Advisors, LLCUnited States$0.756B202